Plasmap Submits Securities Registration Statement... KOSDAQ Listing in October

[Asia Economy Reporter Lee Gwan-ju] Plasmap announced on the 22nd that it has submitted a securities registration statement to the Financial Services Commission and has begun the process of listing on KOSDAQ.

The total number of shares offered by Plasmap is 1,771,000. The desired public offering price range per share is 9,000 to 11,000 KRW, with the total offering amount estimated to be approximately 15.9 billion to 19.5 billion KRW. Demand forecasting for institutional investors will be held on the 20th and 21st of next month, followed by general subscription on the 26th and 27th. The company plans to list on the KOSDAQ market in October through the technology special listing track, with Mirae Asset Securities as the lead underwriter.

Plasmap is a deep-tech venture company that originated in 2015 from the plasma laboratory of the Department of Physics at KAIST (Korea Advanced Institute of Science and Technology). Utilizing plasma technology, it is developing medical device care solutions, starting with low-temperature sterilization (biological inactivation) solutions for surgical instruments and regenerative activation solutions for implants.

The low-temperature sterilization solution developed the world's first impermeable sterilization pouch (STERPACK) and introduced the fastest 7-minute sterilization solution in the global medical device market. Its medical sterilizer (STERLINK) received FDA approval last year, becoming the first non-US company to do so, and has secured contracts worth approximately 150 billion KRW in the global medical device market.

Lim Yoo-bong, CEO of Plasmap, stated, “We will leap forward as a global unicorn company through differentiated plasma technology and medical device care solutions in the global medical device industry.”

This content was produced with the assistance of AI translation services.